Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
intracranial embolism and thrombosis
MeSH D002542 - intracranial embolism and thrombosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D013923:
Thromboembolism
54 Companies
14 Drugs
$
Success rate
D002561:
Cerebrovascular disorders
0 Companies
0 Drugs
Success rate
D002542:
Intracranial embolism and thrombosis
9 Companies
2 Drugs
$
Success rate
D002341:
Carotid artery thrombosis
0 Companies
0 Drugs
Success rate
D020766:
Intracranial embolism
0 Companies
0 Drugs
Success rate
D020767:
Intracranial thrombosis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Genentech
Alteplase
Cathflo Activase
1987-11-13
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
67
%
2/3
Approved:
2
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Genentech
Alteplase
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use
